Carcinoma in situ of endometrium
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
18
|
|
0.300 |
None |
|
0 |
|
|
|
Malignant Uterine Corpus Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
26
|
152
|
0.100 |
None |
1.000 |
1 |
3
|
2016 |
2016 |
Hereditary Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
45
|
12
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Poorly differentiated carcinoma
|
phenotype |
|
Neoplastic Process
|
64
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cancer of Digestive System
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
71
|
15
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Prostate cancer, familial
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
116
|
25
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Follicular adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
183
|
5
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Thyroid Gland Follicular Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
202
|
14
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Familial lichen amyloidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
230
|
24
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Clear-cell metastatic renal cell carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
260
|
11
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2018 |
Endometrial Neoplasms
|
group |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
261
|
32
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Ductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
273
|
11
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.420 |
None |
1.000 |
3 |
11
|
2014 |
2017 |
Aortic Valve Insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
377
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pancreatitis, Chronic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
379
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Hepatoblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
452
|
22
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2015 |
Adult Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
504
|
46
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.050 |
None |
1.000 |
5 |
|
2009 |
2019 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.050 |
None |
1.000 |
5 |
|
2009 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |